---
title: "DERE WILLARD H — Ownership Dossier"
canonical: https://whiteintel.dev/entity/106448fa-e090-5f7a-9e22-47bbc4e5aec9
json: https://whiteintel.dev/api/public/dossier/106448fa-e090-5f7a-9e22-47bbc4e5aec9
identifier: sec:0001311569
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DERE WILLARD H

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001311569`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/106448fa-e090-5f7a-9e22-47bbc4e5aec9  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/106448fa-e090-5f7a-9e22-47bbc4e5aec9  

## Ownership & control

### Holdings / subsidiaries

- **Metagenomi, Inc.** (director) — https://whiteintel.dev/entity/b0a8e817-f711-5554-8bc1-37fa1c84e460
- **BIOMARIN PHARMACEUTICAL INC** (director) — https://whiteintel.dev/entity/da243f5f-5fb4-5808-b258-c3726f1bb8cb
- **Mersana Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/4edf03d1-5dc7-5d54-bee4-8e5ea9d963bc
- **Seres Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/748ec5f3-ae37-5b7c-9c28-228115c35829
- **MPM ACQUISITION CORP** (director) — https://whiteintel.dev/entity/6ba1394a-97c0-5b9d-9529-b52f63e198b8
- **OCERA THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/1f4222fc-aa61-5c82-ba50-a51aebe03896

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DERE WILLARD H**. Human view: https://whiteintel.dev/entity/106448fa-e090-5f7a-9e22-47bbc4e5aec9 · Structured JSON: https://whiteintel.dev/api/public/dossier/106448fa-e090-5f7a-9e22-47bbc4e5aec9._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._